About

Many sources. One thesis.

Synthos Research exists because investing is the surest route most people have to building real wealth — and almost everything about it is designed to feel intimidating, expensive, or rigged for insiders. We think that's backwards. Great research should be clear, honest, and accessible to anyone willing to learn.

What we do

Synthos runs a systematic engine across six sectors — biotech, AI, crypto, energy, commodities — and the global macro regime that ties them together. It reads everything: company filings, clinical trials, prices, and thousands of hours of the smartest investors and thinkers on the planet. Then it synthesizes all of it into one clear, cited thesis per idea.

Every Company Deep Dive carries the same four things, derived systematically, never by gut:

• A 5-year price chart and a year-to-date read versus the S&P 500
• An Exponential Potential score (0–100) — our signature metric, fusing the hard numbers (growth, returns) with what the expert corpus actually says (conviction, network effects, optionality)
• A 5+ year investment rating and a near-term entry zone
• An honest valuation — and when a standard model doesn't fit a business, we say so instead of faking precision

What makes us different

We call it straight. Our first two deep dives were an 87/100 Buy (Eli Lilly) and a 48/100 Avoid (Circle) — both fully argued, both with the receipts. We are not a hype machine. The whole point is to help you tell the difference between a great company at a fair price and a great story at a terrible one.

We fuse the qualitative with the quantitative. Anyone can pull a P/E ratio. Anyone can quote a podcast. Synthos does both at once — grounding every judgment in evidence and tracking, over time, whose calls actually come true.

We're built accessibility-first. Dark, high-contrast, screen-reader friendly, no information hidden behind color alone. Clarity isn't a feature here; it's the entire mission.

How it works

• Free — the weekly macro regime read and one cross-sector signal. Enough to learn from, every week, forever.
• All-Access — the full sector screens, deep dives, valuations, model portfolios, and the Forecaster Scorecard. Everything the engine produces.

We'd rather charge a little to a lot of people than a lot to a few. Wealth-building shouldn't be a country club.

Disclaimer. Synthos Research is an independent research publication for educational and informational purposes only. Nothing here is investment advice, a solicitation, or a recommendation to buy or sell any security, and it is not personalized to your situation. Markets carry risk, including loss of principal. Always do your own due diligence and consult a licensed professional. The author may hold positions in securities discussed.